Baldwin Insurance Group, Inc. current report, 04 December 2019

Filing Summary

Registrant: BRP Group, Inc. The provided metadata identifies Baldwin Insurance Group, Inc., but the filing names BRP Group, Inc. as the registrant.

Filing date: December 4, 2019. The filing concerns the quarter ended September 30, 2019 and reports a Regulation FD disclosure.

Material Disclosure

BRP Group stated that its Q3 2019 Earnings Supplement, previously posted in connection with its December 2, 2019 earnings release and conference call, inadvertently included incorrect data in the tables presenting pro forma 2018 information on slides 7 and 8.

The company furnished a corrected Q3 2019 Earnings Supplement as Exhibit 99.1 to the Form 8-K.

Financial Metrics and Comparisons

The filing itself does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics. It only identifies corrections to pro forma 2018 tables in the earnings supplement; the corrected figures are not included in the provided filing text.

Guidance, Outlook, Risks, and Unusual Items

  • No new guidance or outlook is provided in the filing.
  • The principal unusual item is the correction of erroneous pro forma 2018 data in the previously posted Q3 2019 earnings supplement.
  • The filing states that the information is furnished, not filed, for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except where expressly stated.
  • BRP Group identified itself as an emerging growth company and reported its Class A common stock trading under the symbol BRP on The Nasdaq Global Select Market.

Investor Verification Items

  • Obtain and review Exhibit 99.1 to confirm the corrected pro forma 2018 figures on slides 7 and 8.
  • Reconcile the corrected historical pro forma data with the December 2, 2019 earnings release and Q3 2019 financial statements.
  • Confirm whether the metadata company name should be BRP Group, Inc. or Baldwin Insurance Group, Inc.
  • Assess whether any investor analyses or prior comparisons relied on the incorrect supplement.